Keith S. Manchester - 11 Feb 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
/s/ Keith Manchester
Issuer symbol
ROIV
Transactions as of
11 Feb 2026
Net transactions value
-$32,658,518
Form type
4
Filing time
13 Feb 2026, 21:02:15 UTC
Previous filing
18 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MANCHESTER KEITH S Director C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM /s/ Keith Manchester 13 Feb 2026 0001244828

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Sale $11,334,750 -425,000 -2.6% $26.67 15,928,113 11 Feb 2026 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale $4,008,000 -150,000 -0.94% $26.72 15,778,113 12 Feb 2026 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale $7,359,000 -275,000 -1.7% $26.76 15,503,113 12 Feb 2026 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale $3,994,268 -150,784 -0.97% $26.49 15,352,329 13 Feb 2026 Held by QVT Financial Investment Cayman Ltd. F1
transaction ROIV Common Shares Sale $5,962,500 -225,000 -1.5% $26.50 15,127,329 13 Feb 2026 Held by QVT Financial Investment Cayman Ltd. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.